Lee, Danner & Bass’s Boston Scientific BSX Stock Holding History

Lee, Danner & Bass’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-117	Closed	-$10.4K	–	281
2024 Q4	$10.4K	Buy	+117	New	+$10.3K	﹤0.01%	528

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Lee, Danner & Bass's BSX Position: Q1 2025 in Review

Lee, Danner & Bass sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 117 shares — an estimated $10.4K sold.

Lee, Danner & Bass first reported a position in BSX in Q4 2024 and held it in 1 quarter. The position peaked at $10.4K in Q4 2024. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

Lee, Danner & Bass reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
Lee, Danner & Bass sold 117 Boston Scientific shares in Q1 2025, an estimated $10.4K.
Lee, Danner & Bass first reported a position in Boston Scientific in Q4 2024 and held it in 1 quarter.
Lee, Danner & Bass's Boston Scientific position peaked at $10.4K in Q4 2024.
1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Lee, Danner & Bass's 13F filing for Q1 2025, filed 29 Apr 2025.